JOIN US FOR A MEMORABLE EVENING
benefiting the Scleroderma Foundation of California
Saturday, October 18, 2025
Marina del Rey Marriott
4100 Admiralty Way
Marina del Rey, CA 90292
5:30PM - COCKTAIL RECEPTION & SILENT AUCTION
7:00PM - DINNER & PROGRAM FOLLOWED BY DJ & DANCING
11:00PM - EVENT CONCLUDES
COCKTAIL ATTIRE
This event brings together members of the scleroderma community for an inspiring and festive celebration featuring a silent and live auction, dinner and program, and an evening of music and dancing. Help us honor the strength and resilience of those affected by scleroderma, and to recognize the individuals and organizations making a difference in their lives. This year, we are proud to honor two outstanding partners:
Merck, recipient of the President’s Award, for their long-standing commitment to scleroderma research, innovative therapy development, and efforts to improve outcomes for patients.
The UCLA Scleroderma Center, recipient of the Helen Greenberg Memorial Spirit of Leadership Award, for their exceptional, multi-disciplinary care and commitment to advancing treatment and hope for scleroderma patients.
Scleroderma is a complex autoimmune disease that can affect the skin and internal organs, often with life-altering consequences. There is currently no cure. Since 1989, the Scleroderma Foundation of California has been a lifeline for patients and caregivers, expanding its reach in 2022 to serve communities across California, Arizona, Hawaii, and Nevada.
Proceeds support our mission to EMPOWER the scleroderma community to live BETTER lives through programs dedicated to SUPPORT, EDUCATION, and RESEARCH.
SUPPORT: Inspiring our community through support services and resources for patients including 26 community volunteer driven support groups, one-on-one professional guidance that allows patients to thrive.
EDUCATION: For medical professionals to help them understand and properly diagnosis scleroderma early, and for patients to help them and cope and thrive while living with scleroderma.
RESEARCH: Support patient-oriented research in collaboration with national and international organizations working in scleroderma and related disease fields.
